“Anutin” joined a good news conference Ready to support the development of the mRNA vaccine “ChulaCov19” by the Faculty of Medicine, Chulalongkorn University reveals progress in preparing for human research in Phase 1 this May.
—
On February 18, 2021, Mr. Anutin Charnvirakul, Deputy Prime Minister and Minister of Public Health, together with Prof. Dr. Suthipong Watcharasinthu, Director of Chulalongkorn Hospital. And Dean of the Faculty of Medicine Chulalongkorn University Prof. Kiatrak Rungtham Executive Director of the Covid-19 Vaccine Development Program Vaccine Research Center Faculty of Medicine, Chulalongkorn University and Dr. Nakorn Premsri, director of the National Vaccine Institute. Co-press the news about the development of the vaccine against COVID-19. “ChulaCov19” Of the Faculty of Medicine Chulalongkorn University At Chulalongkorn Hospital, Thai Red Cross Society
—
Featured News
–
Anutin said the government is ready to support the research of the novel coronavirus vaccine. Of the Thailand team It is our joy and encouragement for the COVID-19 vaccine development program. Of the Faculty of Medicine, Chulalongkorn, or “ChulaCov19” that is now making great progress. Will help strengthen the solid foundation of the public health system Self-reliant. The Thai government has provided 63 million doses of the COVID-19 vaccine to immunize the people. In the past, we have the potential to produce a set of PPE masks and reagents by ourselves. As well as being ready for hospital beds, hospital fields, adequate treatment and stability. It is hoped that the ChulaCov19 vaccine will help strengthen the prevention, control and treatment of COVID-19. Of the country to complete the full cycle
—
“Currently, the vaccine market belongs to the sellers. If the vaccine is to be given, it must be paid. Must buy as specified Therefore, Thailand must be self-sufficient. Chulalongkorn University’s COVID-19 Vaccine Research Development Project is nearing success. And we are ready to support all national vaccine development programs as well. Which will ensure the stability of the Thai health system in the future “
–
The ChulaCov19 vaccine is a breakthrough mRNA vaccine. Can prevent and greatly reduce the number of infections in laboratory mice. And stored in normal refrigerator temperature 2-8 degrees Celsius for at least 1 month. Vaccination for a period of 3 months is pending research results. Which is a suitable distance for vaccine transportation and distribution The prototype vaccine is expected to be tested in volunteers around early May and a second version of the vaccine will be developed to support future mutants.
—
Read more …
– .
